Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations

Journal
European journal of gastroenterology & hepatology
Date Issued
2021-05-01
Author(s)
Nakov, Radislav
Suhr, Ole B
Ianiro, Gianluca
Kupcinskas, Juozas
Segal, Jonathon P
Dumitrascu, Dan L
Heinrich, Henriette
Mikolasevic, Ivana
Stojkovic-Lalosevic, Milica
Sarafov, Stayko
Tournev, Ivailo
Nakov, Ventsislav
Wixner, Jonas
DOI
10.1097/MEG.0000000000002030
Abstract
Transthyretin amyloid (ATTR) amyloidosis is an adult-onset, rare systemic disorder characterized by the accumulation of misfolded fibrils in the body, including the peripheral nerves, the heart and the gastrointestinal tract. Gastrointestinal manifestations are common in hereditary (ATTRv) amyloidosis and are present even before the onset of the polyneuropathy in some cases. Delays in diagnosis of ATTRv amyloidosis with gastrointestinal manifestations commonly occur because of fragmented knowledge among gastroenterologists and general practitioners, as well as a shortage of centers of excellence and specialists dedicated to disease management. Although the disease is becoming well-recognized in the societies of Neurology and Cardiology, it is still unknown for most gastroenterologists. This review presents the recommendations for ATTRv amyloidosis with gastrointestinal manifestations elaborated by a working group of European gastroenterologists and neurologists, and aims to provide digestive health specialists with an overview of crucial aspects of ATTRv amyloidosis diagnosis to help facilitate rapid and accurate identification of the disease by focusing on disease presentation, misdiagnosis and management of gastrointestinal symptoms.